share_log

Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Announces $1 Price Target

Benzinga Real-time News ·  Jul 13, 2022 08:20

Cantor Fitzgerald analyst Louise Chen reiterates TherapeuticsMD (NASDAQ:TXMD) with a Neutral and announces $1 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment